- Home
- CHE
CHE
Chemed Corp
as 01-17-2025 4:00pm EST
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 8.0B | IPO Year: | N/A |
| Target Price: | $641.50 | AVG Volume (30 days): | 94.1K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 19.78 | EPS Growth: | 22.57 |
| 52 Week Low/High: | $512.12 - $654.62 | Next Earning Date: | 02-25-2025 |
| Revenue: | $2,377,206,000 | Revenue Growth: | 6.83% |
| Revenue Growth (this year): | 8.28% | Revenue Growth (next year): | 7.06% |
Stock Insider Trading Activity of Chemed Corp (CHE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Judkins Brian C | CHE | VP and Chief Legal Officer | Dec 30 '24 | Buy | $519.50 | 145 | $75,327.50 | 1,678 | |
| LEE SPENCER S | CHE | executive vice president | Nov 27 '24 | Sell | $575.62 | 732 | $421,356.04 | 18,287 | |
| MCNAMARA KEVIN J | CHE | president and CEO | Nov 25 '24 | Sell | $572.77 | 2,000 | $1,145,540.00 | 101,735 | |
| LEE SPENCER S | CHE | executive vice president | Nov 22 '24 | Sell | $565.71 | 1,000 | $565,710.00 | 18,287 |
Latest Chemed Corp News
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
CHE: Raising target price to $561.00
Business Wire
11 days ago
Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare Conference
Zacks
22 days ago
EHC vs. CHE: Which Stock Should Value Investors Buy Now?
Simply Wall St.
23 days ago
Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 31% Undervaluation?
Argus Research
a month ago
CHE: Lowering target price to $543.00
Argus Research
a month ago
CHE: Lowering target price to $551.00
Zacks
a month ago
EHC or CHE: Which Is the Better Value Stock Right Now?
Argus Research
a month ago
CHE: Lowering target price to $575.00
Compare CHE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.